Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Blood
|
October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Caron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Scientific Reports
|
March 13, 2021
Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
Julia M Kempf, Sabrina Weser, Michael D Bartoschek, et al.
Blood
|
August 22, 2018
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles
Johannes C Hellmuth, Abner Louissaint, Monika Szczepanowski, et al.
Frontiers in Immunology
|
November 17, 2022
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Tobias Zeller, Sebastian Lutz, Ira A Münnich, et al.
Blood
|
November 8, 2019
Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles
Annette M Staiger, Eva Hoster, Vindi Jurinovic, et al.
Blood
|
July 16, 2016
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
Vindi Jurinovic, Robert Kridel, Annette M Staiger, et al.
Scientific Reports
|
October 26, 2017
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells
Simon Body, Anna Esteve-Arenys, Hadjer Miloudi, et al.
Cancer Discovery
|
May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation
Oliver Weigert, Nadja Kopp, Andrew A Lane, et al.
Blood
|
July 25, 2022
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals
Nora Philipp, Maryam Kazerani, Alyssa Nicholls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Blood
|
October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Caron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Scientific Reports
|
March 13, 2021
Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
Julia M Kempf, Sabrina Weser, Michael D Bartoschek, et al.
Blood
|
August 22, 2018
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles
Johannes C Hellmuth, Abner Louissaint, Monika Szczepanowski, et al.
Frontiers in Immunology
|
November 17, 2022
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Tobias Zeller, Sebastian Lutz, Ira A Münnich, et al.
Blood
|
November 8, 2019
Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles
Annette M Staiger, Eva Hoster, Vindi Jurinovic, et al.
Blood
|
July 16, 2016
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
Vindi Jurinovic, Robert Kridel, Annette M Staiger, et al.
Scientific Reports
|
October 26, 2017
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells
Simon Body, Anna Esteve-Arenys, Hadjer Miloudi, et al.
Cancer Discovery
|
May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation
Oliver Weigert, Nadja Kopp, Andrew A Lane, et al.
Blood
|
July 25, 2022
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals
Nora Philipp, Maryam Kazerani, Alyssa Nicholls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
Page
of 8